A validated bioanalytical HPLC method for pharmacokinetic evaluation of 2-deoxyglucose in human plasma

Biomedical Chromatography

Volumn 26, Issue 5, 2012, Pages 650-654

  Gounder, Murugesan K ^a   Lin, Hongxia ^a   Stein, Mark ^a   Goodin, Susan ^a   Bertino, Joseph R ^a   Kong, Ah Ng Tony ^a,b   Dipaola, Robert S ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

2 deoxyglucose; Fluorescence derivatization; HPLC; Pharmacokinetics

Indexed keywords

BORIC ACID; FLUORESCENCE; PHARMACOKINETICS; SODIUM COMPOUNDS; TUMORS;

2-DEOXYGLUCOSE; BIOANALYTICAL; CLINICAL TRIAL; FLUORESCENCE DERIVATIZATION; FLUORESCENT METHODS; HPLC; HPLC METHOD; HUMAN PLASMAS; PHARMACOKINETIC EVALUATION; TUMOUR CELLS;

GLUCOSE;

DEOXYGLUCOSE;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERIVATIZATION; DRUG STABILITY; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PLASMA; REPRODUCIBILITY;

EID: 84859439369     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1710     Document Type: Article

References (28)

1. Aft RL, Zhang FW and Gius D. Evaluation of 2-deoxy- d-glucose as a chemotherapeutic agent: mechanism of cell death. British Journal of Cancer 2002; 7: 805-812.
2. Aft RL, Lewis JS, Zhang F, Kim J and Welch MJ. Enhancing targeted radiotherapy by copper(II)diacetyl-bis(N4-methylthiosemicarbazone) using 2-deoxy- d-glucose. Cancer Research 2003; 63: 5496-5504.
3. Anumula KR. Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. Analytical Biochemistry 1994; 220: 275-283.
4. Anumula KR. Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates. Analytical Biochemistry 2006; 350: 1-23.
5. Blough HA and Giuntoli RL. Successful treatment of human genital herpes infections with 2-deoxy- d-glucose. Journal of the Aerican Medical Association 1979; 241: 2798-2801.
6. Casabuono AC, Morion MC, Buchta C, Perego MC and Couto AS. Comparison of micro-enzymatic and high performance anion exchange chromatography methods for the analysis of glucose in human serum. ARKIVOC 2005; xii: 243-252.
7. Cremerius U, Wildberger JE, Borchers H, Zimny M, Jakse G, Gunther RW and Buell U. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study in 50 patients. Urology 1999; 54: 900-904.
8. DiPaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, Bray K, Mathew R, Beaudoin B, Karp C, Stein M, Foran DJ and White E. Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate 2008; 68: 1743-1752.
9. Furler SM, Jenkins AB and Kraegen EW. Effect of insulin on [3H]deoxy- d-glucose pharmacokinetics in the rat. American Journal of Physiology 1988; 255: E806-E811.
10. Hanko VP and Rohrer JS. Determination of carbohydrates, sugar alcohols, and glycols in cell cultures and fermentation broths using high-performance anion-exchange chromatography with pulsed amperometric detection. Analytical Biochemistry 2000; 283: 192-199.
11. Hase S. Pre- and Post-column detection-oriented derivatization techniques in HPLC of carbohydrates. In Carbohydrate Analysis - High Performance Liquid Chromatography and Capillary, Rassi ZE (ed.). Vol. 58. Elsevier Science: Amsterdam, 1995; 555-575.
12. Hsu PP and Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703-707.
13. Hughes DE. Determination of alpha-2-deoxy- d-glucose in topical formulations by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography 1985; 331: 183-186.
14. Kakita H, Kamishima H, Komiya K and Kato Y. Simultaneous analysis of monosaccharides and oligosaccharides by high-performance liquid chromatography with postcolumn fluorescence derivatization. Journal of Chromatography. A 2002; 961: 77-82.
15. Kern KA and Norton JA. Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy- d-glucose. Surgery 1987; 102: 380-385.
16. Liu H, Hu YP, Savaraj N, Priebe W and Lampidis TJ. Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry 2001; 40: 5542-5547.
17. Maher JC, Krishan A and Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy- d-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemotherapy and Pharmacology 2004; 53: 116-122.
18. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR and Lampidis TJ. 2-deoxy- d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Research 2004; 64: 31-34.
19. Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli BA, Banerjee AK, Das S, Jena A, Ravichandran R, Sahi UP, Kumar R, Kapoor N, Kalia VK, Dwarakanath BS and Jain V. Improving cancer radiotherapy with 2-deoxy- d-glucose: phase I/II clinical trials on human cerebral gliomas. International Journal of Radiation Oncology, Biology, Physics 1996; 35: 103-111.
20. Scott WJ, Schwabe JL, Gupta NC, Dewan NA, Reeb SD and Sugimoto JT. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group. The Annals of Thoracic Surgery 1994; 58: 698-703.
21. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetics studies. Conference Report. Pharmaceutical Research 1992; 9: 588-592.
22. Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ and Spitz DR. 2-Deoxy- d-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Research 2007; 67: 3364-3370.
23. Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL, Ravindranath T and Jain V. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme. Strahlentherapie und Onkologie 2005; 181: 507-514.
24. Stein M, Lin H, Jeyamonhan C, Dvorzhinski D, Gounder M, Bray K, Eddy S, Goodin S, White E and DiPaola RS. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 2010; 70: 1388-1394.
25. Umegae Y, Nohta H and Ohkura Y. Simultaneous determination of 2-deoxy- d-glucose and d-glucose in rat serum by high-performance liquid chromatography with post-column fluorescence derivatization. Chemical and Pharmeutical Bulletin (Tokyo) 1990; 38: 963-965.
26. Wallis MG, Wheatley CM, Rattigan S, Barrett EJ, Clark AD and Clark MG. Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes 2002; 51: 3492-3498.
27. Zhang XD, Deslandes E, Villedieu M, Poulain L, Duval M, Gauduchon P, Schwartz L and Icard P. Effect of 2-deoxy- d-glucose on various malignant cell lines in vitro. Anticancer Research 2006; 26: 3561-3566.
28. Zhu Z, Jiang W, McGinley JN and Thompson HJ. 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Research 2005; 65: 7023-7030.